IEX Stock Recent News

Reference is made to the stock exchange announcements issued by IDEX Biometrics ASA (the "Company") on 11 March and 11 April 2025 regarding the successful loan financing of NOK 30 million and the subsequent conversion of such debt to shares in the Company at a subscription price of NOK 0.01 per share, resulting in the issuance of 3,000,000,000 new shares ("Debt Conversion” and “Debt Conversion Shares"), the subsequent offering of up to 600,000,000 new shares at a subscription price equal to the subscription price in the Debt Conversion ("Subsequent Offering" and the "Offer Shares"), and the amendment of a certain senior convertible bond (the "Convertible Bond") issued by an affiliate of Heights Capital Management ("Heights") to the Company, whereby, among other things, the principal amount of the Convertible Bond was reduced to an aggregate principal amount of NOK 49,980,000.

The Nomination Committee of IDEX Biometrics ASA proposes that Morten Opstad, Annika Olsson and Adriana Saitta, all current board members and European residents and nationals, form the new board of directors, with Morten Opstad serving as the Chair. The proposal is that they continue for a new term of two years.

I focus on anticipating market shifts, applying a big-picture, thematic approach to find alpha where others aren't looking. Despite market fragility and high valuations, I'm actively buying cyclical dividend growth stocks before broader sentiment turns positive. Early signs of economic improvement suggest cyclical sectors, especially industrials and transportation, offer exceptional long-term risk/reward.

IDEX Biometrics ASA (the “Company”) refers to its stock exchange announcement on 30 April 2025 regarding notice of an annual general meeting scheduled for 21 May 2025 (the “AGM”).

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corp. (NYSE:IEX) announces a regular quarterly cash dividend of $0.71 per common share, the company's 122nd consecutive quarterly dividend.

Reference is made to the announcement by IDEX Biometrics ASA on 5 May 2025 regarding the results of the exercise of Warrants B. A total of 36,767 Warrants B were exercised, resulting in an aggregate subscription for 36,767 new shares, each Warrant B having an exercise price of NOK 0.15.

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 12 December 2024 regarding the listing of Warrants A and Warrants B on Oslo Stock Exchange. Warrants B were exercisable between 31 March 2025 and 11 April 2025, and all Warrants B not exercised within such time lapsed without compensation to the holder.

IDEX Corporation (NYSE:IEX ) Q1 2025 Earnings Call May 1, 2025 9:00 AM ET Company Participants Jim Giannakouros - Investor Relations Eric Ashleman - President and Chief Executive Officer Abhi Khandelwal - Senior Vice President and Chief Financial Officer Conference Call Participants Mike Halloran - Baird Nathan Jones - Stifel Vlad Bystricky - Citigroup Joe Giordano - Cowen Bryan Blair - Oppenheimer Deane Dray - RBC Capital Markets Brett Linzey - Mizuho Matt Summerville - D.A. Davidson Operator Greetings.

IDEX Corporation designs, manufactures, and sells precise fluid and material handling solutions, operating in three segments. Growth by acquisitions is somewhat risky, but IDEX has done an excellent job of not overpaying for the companies it acquires. The company has a solid history of dividend growth, raising its dividend at a clip of 9% over the past decade.

Strength in the Health & Science Technologies segment aids IEX's first-quarter results.